Cancer has been a severe problem in public health for many years. In the near future, it will continue to post great threat to human health. Fortunately, we keep sharpening our weapon against cancer with the development of numerous therapeutics. Genhouse Bio is dedicated to this war against cancer, setting out on clinical needs to develop next-generation targeted therapeutics for global patients.

Overcome “Undruggable” Targets

Targeted therapeutics are also called biologically guided missiles, which will selectively bind to cancer-specific targets and lead to tumor-specific cell death but spare the normal cells and tissues. Although considerable amounts of oncogenes have been discovered and studied, only very limited part of such research has been successfully translated into viable therapeutics. The rest of those oncogenes become the so-called “undruggable” targets. For instance, kras is the first oncogene discovered in history, the mechanism of which has been extensively studied for years. Whereas, the development of KRAS inhibitors has been thwarted by the inability to identify an accessible binding site on the KRAS protein.

Genhouse Bio is dedicated to overcoming those “undruggable” targets assisted by high-throughput screening, virtual screening and structural biology based molecular design, to provide better and broader therapeutic choices to global cancer patients.

Focus on Original Innovation

Oncogenesis is a very complicated process, whereby normal cells transformed into cancer cells, involving the immune system, metabolism, cell cycle regulation and many other biological functions. Despite of decades of research, our knowledge about oncogenesis is still limited—novel oncogenes and pathways, and their therapeutic potentials are still awaiting exploration.

On account of ten-year experience in translational medicine, Genhouse Bio has accumulated first-hand, real-world clinical data to dig into novel targets and mechanisms of action. Genhouse Bio focuses on basic research and original innovation to develop new drug candidates with first-in-class potentials, which will bring brand-new hope to global cancer patients.

Privacy Statement

Genhouse Bio (Suzhou) Ltd. (“Genhouse” or “We”) respects the privacy of visitors (“Users”) to our website (“Site”), so we have developed this website privacy statement (“Privacy Statement”). This Privacy Statement indicates what information we collect about you and how that information is used. We may update the content of the Privacy Statement and suggest reading it regularly when you visit our Site.

Personal Information Collected by Genhouse

When you visit the Site, usually we will not collect any personal information from you. We might track your DNS and analyze the data to obtain understanding on visit trends. However, your identity will always remain anonymous, unless you specifically and knowingly provide it to us. When you provide such information, we will collect your personal information, such as when you contact us through the phone number or email address posted on the Site. But no matter when and how we collect your personal information, we will always provide link to this Privacy Statement. By willingly providing your personal information to us, you make the consent that we could use the information collected according to this Privacy Statement and admit that the information will be transferred from your locale to our office or server.

Information Disclosures and Sharing

Except as provided below, we will not share or sell your Personal Information with third parties unless otherwise stated by this Privacy Statement.

We might share your information according to this Privacy Statement, with Related Party who have consented to follow this Privacy Statement. Your personal information might also be transferred to other Related Party who represents us for purpose stated when we collect those information or other purposes permitted by law, such as Site evaluation, data management or technical support.

We might sell or buy business or assets during our operation. If Genhouse is acquired, merged, reorganized or dissolved or other alike situations happened, personal information might be part of the assets transferred. We may share personal information to respond to duly authorized subpoenas or other lawful information requests of governmental authorities, including to meet national security or law enforcement requirements, to provide Internet security, or where required by law.


We might put a digital tag (more precisely “cookies”) on your hard disk driver for the server to recognize your computer and track usage information. Cookies will not reveal your personal information and you could always stay anonymous to us. The information we collected from Cookies will only be used for internal purpose and improve the service we provided to you through the Site. Users of our Site always have the option of disabling cookies via their browser preferences. If under any circumstances we collected your personal information, we will always inform you with your planned usage, contact and any Third Party that might get this information. All your personal information will maintain secrecy.

Links to Other Websites

If you apply to a job through our Site, you might be directed to other websites operated by Third Party. This Privacy Statement does not extend to any of these websites. Genhouse will not be responsible for any personal information collected by these websites operated by Third Party. Therefore, for any cases that a Third Party collect or use your personal information, Genhouse will not be legally responsible. We advise you to contact those websites directly and get their policies on personal information collection, safety, sharing and disclosure.

Contact Information

If you have any questions about our Privacy Statement, please do not hesitate to contact us at [].

Effective and Last Updated: April 15th 2021